Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients
一项随机、对照的 I/II 期临床试验,研究地拉韦啶 (U-90152S) 与传统核苷类药物联合治疗 1 型人类免疫缺陷病毒感染患者的疗效。
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.40.7.1657
Davey, R T Jr; Chaitt, D G; Reed, G F; Freimuth, W W; Herpin, B R; Metcalf, J A; Eastman, P S; Falloon, J; Kovacs, J A; Polis, M A; Walker, R E; Masur, H; Boyle, J; Coleman, S; Cox, S R; Wathen, L; Daenzer, C L; Lane, H C